• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 8 of 100
GSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales
Finance
GSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales
By AFPFebruary 5, 2025
Albert Bourla, chief executive officer of Pfizer Inc., during a panel session at the World Economic Forum
Health
Pfizer CEO had dinner with RFK Jr.: ‘I’m cautiously optimistic’ in spite of his history with vaccines
By Hallie SteinerFebruary 4, 2025
Close-up of cast metal sign for the pharmaceutical company Merck
Health
Merck touts 20 new ‘blockbuster’ drugs in development with $50 billion potential
By Hallie SteinerFebruary 4, 2025
Row of medical vials and syringe
Health
Pfizer’s Covid boost overshadowed by Kennedy threat to vaccines
By Bloomberg and Damian GardeFebruary 4, 2025
Novo Nordisk advertising logo on facade building, Danish pharmaceutical healthcare giant Novo Nordisk AS, production innovative drugs, obesity treatment Ozempic, Mainz, Germany June 15, 2024
Health
Investors are growing anxious about Novo Nordisk’s silence since disappointing CagriSema weight loss drug results
By Ryan HoggFebruary 4, 2025
An older man wearing a business suit holds a pill in one hand and a glass of water in the other.
Health
The aspirin mistake: 29 million take it daily, not realizing costs outweigh benefits
By Lindsey LeakeFebruary 3, 2025
A person stands on a scale.
Health
Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
By Lindsey LeakeFebruary 3, 2025
Ozempic and Wegovy medications side by side
Health
Ozempic and Wegovy surge to national approval with most U.S. adults considering it ‘a good thing’ to treat obesity
By The Associated Press, Kenya Hunter and Linley SandersJanuary 31, 2025
Close-up view of man in blue button-down shirt placing pills in his hand.
Health
New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids
By Bloomberg and Gerry SmithJanuary 31, 2025
Pattern of colorful pills and capsules on beige background.
Health
Cigna plans to limit out-of-pocket drug costs for U.S. patients
By Bloomberg and John TozziJanuary 30, 2025
The increase in online searches for obesity management drugs in recent years correlated to a surge in dispensed prescriptions, according to a new study from the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease.
Health
Online searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says. Here’s what could happen next
By Lindsey LeakeJanuary 29, 2025
A person, with only the midsection visible, injects Wegovy under the skin of their stomach.
Finance
Novo Nordisk stock surges 7% after Ozempic maker’s latest weight-loss drug shows promise
By Greg McKennaJanuary 24, 2025
Man, seen from the back, sitting on unmade bed and looking out a window.
Mind
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
By Beth GreenfieldJanuary 22, 2025
Days before President Donald Trump took office a second time, the Department of Health and Human Services granted Moderna $590 million for the development of mRNA vaccines for bird flu and other influenza viruses.
Health
As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
By Lindsey LeakeJanuary 22, 2025
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
Health
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
By Lindsey LeakeJanuary 21, 2025
1...
  • 6
  • 7
  • 8
  • 9
  • 10
...100
Most Popular
Europe
‘It’s only when you see 49-ton trucks in China running on batteries that you realize how serious electrification is’: Octopus Energy CEO Greg Jackson on Europe’s incumbency problemplaceholder alt text
By Kamal AhmedOctober 30, 2026
Real Estate
The Pentagon and Britain are bracing for the power to go out. The ultrawealthy got there first, with backup generators, escape homes, and stockpilesplaceholder alt text
By Sydney LakeOctober 30, 2026
North America
Pentagon orders bases to plan for 90 days without the grid as Britain urges families to stockpile food and waterplaceholder alt text
By Bilin LinOctober 26, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.